Nom du produit:2-Fluoro-4-nitrotoluene

IUPAC Name:2-fluoro-1-methyl-4-nitrobenzene

CAS:1427-07-2
Formule moléculaire:C7H6FNO2
Pureté:95%
Numéro de catalogue:CM244361
Poids moléculaire:155.13

Unité d'emballage Stock disponible Prix($) Quantité
CM244361-500g in stock ŴȬɅ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1427-07-2
Formule moléculaire:C7H6FNO2
Point de fusion:-
Code SMILES:CC1=CC=C([N+]([O-])=O)C=C1F
Densité:
Numéro de catalogue:CM244361
Poids moléculaire:155.13
Point d'ébullition:
N° Mdl:
Stockage:

Column Infos

Enzalutamide
Aug. 23, 2023, FDA grants priority review for XTANDI(enzalutamide) in non-metastatic castration-sensitive prostate cancer with high-risk biochemical recurrence.
XTANDI (enzalutamide) is an androgen receptor signaling inhibitor. Androgen receptor inhibitors interfere with the connection between androgens and androgen receptors. This can help slow cancer cell growth.XTANDI is currently approved for one or more of these indications in more than 100 countries, including in the U.S., European Union and Japan. Over one million patients have been treated with XTANDI globally.